Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03284593

Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition

Sponsor: University Hospital, Toulouse

View on ClinicalTrials.gov

Summary

The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared patients treated with intensive chemotherapy or azacitidine within two centres.

Official title: Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition at Toulouse and Bordeaux University Hospital

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

199

Start Date

2014-12

Completion Date

2030-12

Last Updated

2020-07-30

Healthy Volunteers

No

Interventions

DRUG

intensive chemotherapy

DRUG

Azacitidine

Locations (2)

University Hospital Bordeaux

Bordeaux, France

University Hospital Toulouse

Toulouse, France